Skip to main content
logo
Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
112.59
+5.02 (4.67%)
Jul 30, 2026, 4:00 PM EDT - Market closed

Mirum Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-798.84-23.36-87.94-163.42-135.67-83.99
Depreciation & Amortization
25.0724.2423.6310.833.240.6
Stock-Based Compensation
91.8271.4248.4435.0227.0123.09
Other Adjustments
417.183.243.665.846.33-89.44
Change in Receivables
-44.11-48.06-11.43-43.97-20.73-
Changes in Inventories
-7.7-8.45-3.17-0.97-3.44-0.5
Changes in Accrued Expenses
95.6150.140.3130.787.6322.92
Changes in Other Operating Activities
50-13.32-3.13-5.05-4.51-5.18
Operating Cash Flow
-170.9855.8310.33-70.94-120.14-132.76
Operating Cash Flow Growth
-440.70%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.58-0.95-0.99-0.11-0.28-0.02
Purchases of Intangible Assets
--20-20---19
Purchases of Investments
-98.7-97.43-89.03-27.33-132.32-198.03
Proceeds from Sale of Investments
90.8874.4319.89153140.3157.6
Cash Acquisitions
----212.76--
Other Investing Activities
-----108
Investing Cash Flow
-19.39-23.95-90.13-107.27.748.55

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---305.3--
Net Long-Term Debt Issued (Repaid)
---305.3--
Issuance of Common Stock
303.8640.1417.7227.15114.649.01
Net Common Stock Issued (Repurchased)
303.8640.1417.7227.15114.649.01
Other Financing Activities
----195.86-5.5564.45
Financing Cash Flow
303.8640.1417.7336.6109.0973.47

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.93.22-1.3-0.130.01-
Net Cash Flow
114.3975.24-63.4158.32-3.34-10.75

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-172.5554.879.33-71.05-120.41-132.78
Free Cash Flow Growth
-488.01%----
FCF Margin
-30.29%10.53%2.77%-38.12%-156.26%-693.81%
Free Cash Flow Per Share
-3.181.090.20-1.74-3.54-4.38
Levered Free Cash Flow
-637.4428.27-31.29177.36-133.03-66.17
Unlevered Free Cash Flow
-636.427.49-31.99-74.35-122.67-155.67
SEC Filings: 10-K · 10-Q